Evidence map›Paper›PMID 32424714›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2020

Green synthesis of gold nanoparticles using extracellular metabolites of fish gut microbes and their antimicrobial properties.

T Rajasekar, K Karthika, G Muralitharan, A Maryshamya, S Sabarika, S Anbarasu, K Revathy, N Prasannabalaji, S Kumaran

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Biosynthesis of gold nanoparticles by Penicillium rubens and catalytic detoxification of ochratoxin A and organic dye pollutants.International microbiology : the official journal of the Spanish Society for Microbiology · 2023
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

T RajasekarCentre for Drug Discovery and Development, Sathyabama Institute of Science and Technology (Deemed to be University) Jeppiaar Nagar, Rajiv Gandhi Road, Chennai, Tamil Nadu, 600 119, India.
K KarthikaDepartmentof Microbiology, Centre of Excellence in Life Sciences, Bharathidasan University, Tiruchirappalli, Tami Nadu, 620 024, India.
G MuralitharanDepartmentof Microbiology, Centre of Excellence in Life Sciences, Bharathidasan University, Tiruchirappalli, Tami Nadu, 620 024, India. microraja09@gmail.com.
A MaryshamyaCentre for Drug Discovery and Development, Sathyabama Institute of Science and Technology (Deemed to be University) Jeppiaar Nagar, Rajiv Gandhi Road, Chennai, Tamil Nadu, 600 119, India.
S SabarikaDepartmentof Microbiology, Centre of Excellence in Life Sciences, Bharathidasan University, Tiruchirappalli, Tami Nadu, 620 024, India.
S AnbarasuCentre for Drug Discovery and Development, Sathyabama Institute of Science and Technology (Deemed to be University) Jeppiaar Nagar, Rajiv Gandhi Road, Chennai, Tamil Nadu, 600 119, India.
K RevathyCentre for Drug Discovery and Development, Sathyabama Institute of Science and Technology (Deemed to be University) Jeppiaar Nagar, Rajiv Gandhi Road, Chennai, Tamil Nadu, 600 119, India.
N PrasannabalajiP. G. & Research Departments of Microbiology, Sri Sankara Arts and Science College (Autonomous), Kanchipuram, Tamil Nadu, India.
S KumaranDepartment of Biotechnology, Sathyabama Institute of Science and Technology (Deemed to be University) Jeppiaar Nagar, Rajiv Gandhi Road, Chennai, Tamil Nadu, 600 119, India.
Sathyabama Institute of Science and Technology · INBharathidasan University · IN

Funding

Science and Engineering Research Board ECR/2015/000460
6 · The paper itself

Abstract

In the present study, we synthesis nanoparticles using biosynthesis methods because of the eco-friendly approach. Gold nanoparticles were synthesized using extracellular metabolites of marine bacteria (Rastrelliger kanagurta, Selachimorpha sp., and Panna microdon). After the synthesis gold nanoparticles checked their antibacterial and antimycobacterial activities. Here we have few techniques that have been used for characterizing the gold nanoparticles followed by ultraviolet (UV)-visible spectrophotometer analysis, Fourier transform-infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscope (SEM), and transmission electron microscopy (TEM). We observed the formation of gold nanoparticles using UV-Vis spectroscopy (UV-Vis). FT-IR spectroscopy results of the extracellular metabolites showed that different characteristic functional groups are responsible for the bioreduction of gold ions. In the recent years, we used zebrafish for an animal model to estimate nanoparticle toxicity and biocompatibility. We tested toxicity of the gold nanoparticle using the zebrafish larvae that are growing exponentially. Sample 1 showed a good antimicrobial activity, and sample 5 showed a good antimycobacterial activity. Based on the UV spectrophotometer, sample 1 is used for further studies. Color change and UV spectrum confirmed gold nanoparticles. Based on the TEM and SEM particles, size was measured and ranged between 80 and 45 nm, and most of the particles are spherical and are in rod shape. XRD result showed the gold nanoparticles with crystalline nature. Toxicity studies in the zebrafish larvae showed that 50 μg ml

Indexed as

Gastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsBacteriaCulture Media, ConditionedEmbryo, NonmammalianFishesGoldGreen Chemistry TechnologyMetal NanoparticlesZebrafishAnti-Bacterial AgentsCulture Media, ConditionedGoldGold nanoparticlesMarine fishMycobacterium tuberculosis

Identifiers

PMID32424714
PMCPMC7455640
OpenAlexW3026154752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.